These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 7861580)

  • 1. Anti-neutrophil cytoplasmic auto antibodies (ANCA) in Pakistani patients with systemic vasculitides.
    Ahmed TA; Malik IA; Khan AA; Shah ST; Hameed A; Haleem SA; Farooqui A; Amin SJ
    J Pak Med Assoc; 1994 Dec; 44(12):272-5. PubMed ID: 7861580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of antineutrophil cytoplasmic autoantibodies in diagnosing vasculitis in a Chinese patient population.
    Li PK; Leung JC; Lai FM; Wang A; Lui SF; Leung CB; Lai KN
    Am J Nephrol; 1994; 14(2):99-105. PubMed ID: 7915885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antineutrophil cytoplasmic antibodies.
    Bosch X; Guilabert A; Font J
    Lancet; 2006 Jul; 368(9533):404-18. PubMed ID: 16876669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-neutrophil cytoplasm antibodies (ANCA).
    Savige JA; Davies DJ
    Aust N Z J Med; 1990 Jun; 20(3):271-4. PubMed ID: 2196872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antineutrophil cytoplasmic antibodies: a new diagnostic tool].
    Papo T; Meyer O; Piette JC
    Rev Med Interne; 1991; 12(1):60-5. PubMed ID: 2041916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between disease activity and anti-neutrophil cytoplasmic antibody concentration in long-term management of systemic vasculitis.
    De'Oliviera J; Gaskin G; Dash A; Rees AJ; Pusey CD
    Am J Kidney Dis; 1995 Mar; 25(3):380-9. PubMed ID: 7872315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Republished: Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
    Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
    Postgrad Med J; 2014 May; 90(1063):290-6. PubMed ID: 24737903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antineutrophilic cytoplasmic antibodies (ANCA) in inflammatory rheumatic diseases: immunodiagnostic and immunopathogenetic aspects].
    Csernok E; Gross WL
    Z Rheumatol; 1995; 54(1):26-38. PubMed ID: 7725808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-neutrophil cytoplasmic antibody (ANCA) in necrotising vasculitides with renal involvement.
    Bhuyan UN; Dash SC; Tiwari SC
    J Assoc Physicians India; 1993 Aug; 41(8):492-5. PubMed ID: 7904992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antineutrophil cytoplasmic autoantibodies in systemic vasculitis].
    Hagemo JS; Aasarød K; Moen T
    Tidsskr Nor Laegeforen; 2002 May; 122(12):1185-8. PubMed ID: 12089844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antineutrophil cytoplasmic autoantibodies (ANCA)--markers in diagnosis and monitoring systemic vasculitides.
    Cristea A; Badea T; Bodizs G; Olinic N
    Rom J Intern Med; 1995; 33(1-2):37-46. PubMed ID: 8535351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody.
    Westman KW; Selga D; Bygren P; Segelmark M; Baslund B; Wiik A; Wieslander J
    Kidney Int; 1998 May; 53(5):1230-6. PubMed ID: 9573537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antineutrophil cytoplasmic antibodies: clinical characteristics of 10 patients with the perinuclear pattern of immunofluorescence on ANCA testing.
    Ecklund SR; Saluta GS; Agudelo CA; Pisko EJ
    South Med J; 1992 Feb; 85(2):132-8. PubMed ID: 1738878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of antineutrophil cytoplasmic antibody (c-ANCA) and clinical criteria in diagnosing Wegener's granulomatosis.
    Rao JK; Allen NB; Feussner JR; Weinberger M
    Lancet; 1995 Oct; 346(8980):926-31. PubMed ID: 7564726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytoplasm antibodies of polynuclear neutrophils in Wegener's granulomatosis and systemic vasculitis].
    Gavaud C; Ninet J; Monier JC; Coppere B; Pinede L; Girard-Madoux MH; Rousset H; Levrat R; Massot C; Pasquier J
    Presse Med; 1993 Oct; 22(33):1679-86. PubMed ID: 8278321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies directed against neutrophils (C-ANCA and P-ANCA) are of distinct diagnostic value in systemic vasculitis.
    Venning MC; Quinn A; Broomhead V; Bird AG
    Q J Med; 1990 Dec; 77(284):1287-96. PubMed ID: 2290922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-neutrophil cytoplasmic autoantibodies--a serologic marker for vasculitides.
    Jennette JC; Falk RJ; Wilkman AS
    Ann Acad Med Singap; 1995 Mar; 24(2):248-53. PubMed ID: 7653968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-neutrophil cytoplasmic antibodies: a new class of autoantibodies in glomerulonephritis, vasculitis and other inflammatory disorders.
    Tervaert JW; Stegeman CA; Brouwer E; Mulder AH; Limburg PC; Kallenberg CG
    Neth J Med; 1994 Dec; 45(6):262-72. PubMed ID: 7838242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antineutrophil cytoplasmic antibodies (ANCA): diagnostic utility and potential role in the pathogenesis of vasculitis.
    Malenica B; Rudolf M; Kozmar A
    Acta Dermatovenerol Croat; 2004; 12(4):294-313. PubMed ID: 15588565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The specificity of anti-neutrophil cytoplasm autoantibodies in systemic vasculitides.
    Lai KN; Jayne DR; Brownlee A; Lockwood CM
    Clin Exp Immunol; 1990 Nov; 82(2):233-7. PubMed ID: 1978701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.